Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: Disease Progression and IDH1[original query] |
---|
Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia. Haematologica 2012 Feb 97 (2): 246-50. Fried Isabella, Bodner Claudia, Pichler Monika M, Lind Karin, Beham-Schmid Christine, Quehenberger Franz, Sperr Wolfgang R, Linkesch Werner, Sill Heinz, Wölfler Albe |
Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysis. PloS one 2014 9 (6): e100206. Jin Jie, Hu Chao, Yu Mengxia, Chen Feifei, Ye Li, Yin Xiufeng, Zhuang Zhengping, Tong Hongy |
Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2015 Sep 22 (9): 1425-9. Kong Doo-Sik, Kim Hong Rye, Choi Yoon-Ra, Seol Ho Jun, Lee Jung-Il, Nam Do-Hy |
TET2 binds the androgen receptor and loss is associated with prostate cancer. Oncogene 2016 Nov . Nickerson M L, Das S, Im K M, Turan S, Berndt S I, Li H, Lou H, Brodie S A, Billaud J N, Zhang T, Bouk A J, Butcher D, Wang Z, Sun L, Misner K, Tan W, Esnakula A, Esposito D, Huang W Y, Hoover R N, Tucker M A, Keller J R, Boland J, Brown K, Anderson S K, Moore L E, Isaacs W B, Chanock S J, Yeager M, Dean M, Andresson |
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 1 25 (6): 1142-1151. Tamari Roni, Rapaport Franck, Zhang Nan, McNamara Caroline, Kuykendall Andrew, Sallman David A, Komrokji Rami, Arruda Andrea, Najfeld Vesna, Sandy Lonette, Medina Juan, Litvin Rivka, Famulare Christopher A, Patel Minal A, Maloy Molly, Castro-Malaspina Hugo, Giralt Sergio A, Weinberg Rona S, Mascarenhas John O, Mesa Ruben, Rondelli Damiano, Dueck Amylou C, Levine Ross L, Gupta Vikas, Hoffman Ronald, Rampal Raajit |
Association of Clinicopathological Features With Outcome in Chondrosarcomas of the Head and Neck. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2020 9 164 (4): 807-814. Asioli Sofia, Ruengwanichayakun Poosit, Zoli Matteo, Guaraldi Federica, Sollini Giacomo, Greco Paolo, Facco Carla, Gibertoni Dino, Jiménez Brayan Vega, Benini Stefania, Turri-Zanoni Mario, Pasquini Ernesto, Mazzatenta Diego, Foschini Maria Pia, Righi Alber |
ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome. Blood advances 2021 9 6 (3): 793-807. West Robert R, Calvo Katherine R, Embree Lisa J, Wang Weixin, Tuschong Laura M, Bauer Thomas R, Tillo Desiree, Lack Justin, Droll Stephenie, Hsu Amy P, Holland Steven M, Hickstein Dennis |
Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax. Leukemia research 2022 9 122 106942. Bewersdorf Jan Philipp, Shallis Rory M, Derkach Andriy, Goldberg Aaron D, Stein Anthony, Stein Eytan M, Marcucci Guido, Zeidan Amer M, Shimony Shai, DeAngelo Daniel J, Stone Richard M, Aldoss Ibrahim, Ball Brian J, Stahl Maximili |
A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (13): 2733-2737. Casak Sandra J, Pradhan Shan, Fashoyin-Aje Lola A, Ren Yi, Shen Yuan-Li, Xu Yuan, Chow Edwin Chiu Yuen, Xiong Ye, Zirklelbach Jeanne Fourie, Liu Jiang, Charlab Rosane, Pierce William F, Fesenko Nataliya, Beaver Julia A, Pazdur Richard, Kluetz Paul G, Lemery Steven |
BCR-ABL1 is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia. Blood science (Baltimore, Md.) 2022 12 4 (4): 199-204. Zhang Yanqing, Bi Hailiang, Wang Ying, Chen Long, Pan Jiaqi, Xu Ping, Wang Wei, Yang Shaob |
Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 2024 4 8 e2300407. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: